Sophia S. Chen

Array ( [id] => 221144 [patent_doc_number] => 07608690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'IL-B30 antibodies' [patent_app_type] => utility [patent_app_number] => 11/006154 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19597 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608690.pdf [firstpage_image] =>[orig_patent_app_number] => 11006154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221144 [patent_doc_number] => 07608690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'IL-B30 antibodies' [patent_app_type] => utility [patent_app_number] => 11/006154 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19597 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608690.pdf [firstpage_image] =>[orig_patent_app_number] => 11006154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075246 [patent_doc_number] => 20050148514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Method and composition for treatment of angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/004273 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19620 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148514.pdf [firstpage_image] =>[orig_patent_app_number] => 11004273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921526 [patent_doc_number] => 20060240064 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2006-10-26 [patent_title] => 'Medical implants and fibrosis-inducing agents' [patent_app_type] => utility [patent_app_number] => 11/001422 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 394000 [patent_no_of_claims] => 287 [patent_no_of_ind_claims] => 127 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0240/20060240064.pdf [firstpage_image] =>[orig_patent_app_number] => 11001422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004646 [patent_doc_number] => 20050169959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Medical implants and fibrosis-inducing agents' [patent_app_type] => utility [patent_app_number] => 11/001421 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 156773 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169959.pdf [firstpage_image] =>[orig_patent_app_number] => 11001421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004646 [patent_doc_number] => 20050169959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Medical implants and fibrosis-inducing agents' [patent_app_type] => utility [patent_app_number] => 11/001421 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 156773 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169959.pdf [firstpage_image] =>[orig_patent_app_number] => 11001421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004645 [patent_doc_number] => 20050169958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Medical implants and fibrosis-inducing agents' [patent_app_type] => utility [patent_app_number] => 11/001420 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 394064 [patent_no_of_claims] => 159 [patent_no_of_ind_claims] => 69 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169958.pdf [firstpage_image] =>[orig_patent_app_number] => 11001420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921526 [patent_doc_number] => 20060240064 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2006-10-26 [patent_title] => 'Medical implants and fibrosis-inducing agents' [patent_app_type] => utility [patent_app_number] => 11/001422 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 394000 [patent_no_of_claims] => 287 [patent_no_of_ind_claims] => 127 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0240/20060240064.pdf [firstpage_image] =>[orig_patent_app_number] => 11001422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991408 [patent_doc_number] => 20050090445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Truncated keratinocyte growth factor (KGF) having increased biological activity' [patent_app_type] => utility [patent_app_number] => 10/998425 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16460 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090445.pdf [firstpage_image] =>[orig_patent_app_number] => 10998425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411108 [patent_doc_number] => 07282203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Use of NOTCH pathway interfering agents for treatment of plasma cell disorders' [patent_app_type] => utility [patent_app_number] => 10/996651 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 4975 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282203.pdf [firstpage_image] =>[orig_patent_app_number] => 10996651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6963059 [patent_doc_number] => 20050216962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species' [patent_app_type] => utility [patent_app_number] => 10/991343 [patent_app_country] => US [patent_app_date] => 2004-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 28003 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20050216962.pdf [firstpage_image] =>[orig_patent_app_number] => 10991343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074342 [patent_doc_number] => 20050147610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'IL-18 binding proteins' [patent_app_type] => utility [patent_app_number] => 10/988360 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44282 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147610.pdf [firstpage_image] =>[orig_patent_app_number] => 10988360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 448314 [patent_doc_number] => 07250276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Human IL-1 epsilon DNA and polypeptides' [patent_app_type] => utility [patent_app_number] => 10/986744 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16732 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250276.pdf [firstpage_image] =>[orig_patent_app_number] => 10986744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075244 [patent_doc_number] => 20050148512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Medical implants and fibrosis-inducing agents' [patent_app_type] => utility [patent_app_number] => 10/986230 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 394065 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148512.pdf [firstpage_image] =>[orig_patent_app_number] => 10986230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982790 [patent_doc_number] => 20050152860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Methods for lightening skin and hair' [patent_app_type] => utility [patent_app_number] => 10/963432 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13024 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152860.pdf [firstpage_image] =>[orig_patent_app_number] => 10963432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230725 [patent_doc_number] => 20050079173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Inhibitor protein of the wnt signal pathway' [patent_app_type] => utility [patent_app_number] => 10/960235 [patent_app_country] => US [patent_app_date] => 2004-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3064 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079173.pdf [firstpage_image] =>[orig_patent_app_number] => 10960235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7176107 [patent_doc_number] => 20050123538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Polynucleotides encoding novel ErbB-2 polypeptides and kits and methods using same' [patent_app_type] => utility [patent_app_number] => 10/956373 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 53144 [patent_no_of_claims] => 209 [patent_no_of_ind_claims] => 70 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123538.pdf [firstpage_image] =>[orig_patent_app_number] => 10956373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983813 [patent_doc_number] => 20050153883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Composition for stimulating de novo bone induction' [patent_app_type] => utility [patent_app_number] => 10/947394 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2608 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153883.pdf [firstpage_image] =>[orig_patent_app_number] => 10947394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5826882 [patent_doc_number] => 20060062767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Method of intervertebral disc treatment using articular chondrocyte cells' [patent_app_type] => utility [patent_app_number] => 10/946299 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1709 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062767.pdf [firstpage_image] =>[orig_patent_app_number] => 10946299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4909143 [patent_doc_number] => 20080019909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Modulation of Programmed Necrosis' [patent_app_type] => utility [patent_app_number] => 10/571799 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20459 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019909.pdf [firstpage_image] =>[orig_patent_app_number] => 10571799 [rel_patent_id] =>[rel_patent_doc_number] =>)